DUPIXENT

Orphan Drug Designations

The following drugs have received orphan drug designation from the FDA for bullous pemphigoid. Orphan designation reflects regulatory interest and does not indicate approval for treatment.

Gene therapy approaches for bullous pemphigoid have been reported in the published literature.

250 publications have been identified in PubMed for bullous pemphigoid. Research spans Case Report / Case Series (28%), Review / Meta-Analysis (24%), and Epidemiology / Natural History (16%).

Recent Publications

• Didona D (2026). [PMID: 41994451](https://pubmed.ncbi.nlm.nih.gov/41994451/). *Front Med (Lausanne)*. [Case Report / Case Series]

• Breakell T (2026). [PMID: 41979852](https://pubmed.ncbi.nlm.nih.gov/41979852/). *Dermatologie (Heidelb)*. [Case Report / Case Series]

• Lawson K (2026). [PMID: 42022890](https://pubmed.ncbi.nlm.nih.gov/42022890/). *JID Innov*. [Basic Science / Preclinical]

• Wang Z (2026). [PMID: 42094004](https://pubmed.ncbi.nlm.nih.gov/42094004/). *Front Immunol*. [Review / Meta-Analysis]

• Alqahtani M (2026). [PMID: 41653489](https://pubmed.ncbi.nlm.nih.gov/41653489/). *Ann Dermatol Venereol*. [Epidemiology / Natural History]

• Zou M (2026). [PMID: 41888879](https://pubmed.ncbi.nlm.nih.gov/41888879/). *Exp Dermatol*. [Epidemiology / Natural History]

• Lei Y (2026). [PMID: 41870227](https://pubmed.ncbi.nlm.nih.gov/41870227/). *American journal of therapeutics*. [Case Report / Case Series]

• Bohrnstedt G 2nd (2026). [PMID: 42282932](https://pubmed.ncbi.nlm.nih.gov/42282932/). *JAAD Case Rep*. [Case Report / Case Series]

• Wang SH (2026). [PMID: 42094699](https://pubmed.ncbi.nlm.nih.gov/42094699/). *J Inflamm Res*. [Epidemiology / Natural History]

• Albadri Z (2026). [PMID: 42186604](https://pubmed.ncbi.nlm.nih.gov/42186604/). *J Multimorb Comorb*. [Epidemiology / Natural History]